Free Pharma & Biopharm Support from Pharma IQ
Pharmaceutical and biotech professionals make up the 30,000 strong global Pharma IQ community, benefitting from free membership to a unique pharmaceutical learning and networking portal.
Pharma IQ offers a unique multimedia platform for the community to engage through a series of high level pharma conferences, online events, training courses, articles, white papers, videos, podcasts, webinars and reports.
Pharma IQ focuses on all areas of drug development for both chemical products and biologics within the pharma industry with special focus on:
Respected as a credible source of content in the industry, our contributors include thought leaders and senior figures from leading organisations, including Pfizer, Roche, FDA, DIA, EMA, Eli Lilly, Merck, GSK, Novartis, Abbott and AstraZeneca.
Members can access a wealth of pharma resources including access to our growing library of multi-media pharma presentations from senior pharmaceutical leaders around the world, weekly newsletters to keep you updated on new pharma content and special Pharma IQ members-only discounts on renowned pharma events such as Cool Chain Logistics, Clinical Trial Supply, ELNs, Pre-Formulation and Formulation, Compound Management and Global Clinical Outsourcing Forum.
GBI is China’s leader in pharmaceutical and biotechnology data intelligence and consulting services. GBI provides in-depth analysis and insights that enable subscribers to stay ahead of China’s pharmaceutical, biotechnology and healthcare industries. Our offerings include:
Our goal is to create a transparent operating environment for our clients, and provide the insights into the competitive landscape they need in order to capitalize on the tremendous opportunities available in China. Our clients depend on the news, data, and analytics we provide to make informed decisions every day.
GBI's clients include most multinational pharmaceutical companies and a leading group of biotechnology companies, healthcare companies, investors, consultants, law firms and financial analysts.
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical / biopharmaceutical industry and market. Pharma China caters for the growing needs of the international pharmaceutical industry by providing up‐to‐date and insightful intelligence on China’s burgeoning but increasingly complex healthcare marketplace. Pharma China is subscribed to by almost all multinational pharmaceutical companies, leading CROs, investment banks, consulting firms, industry associations, and numerous governmental orginizations.